Quantum-Potential-Feature

Our past has something to say. 2025 Guggenheim Fellow Larisa DeSantis is ready to translate. Read More

Crucial research by Neil Osheroff and his lab leads to approval of the first new class of antibacterial drugs in decades. The drug, gepotidacin, developed by GlaxoSmithKline under the brand name Blujepa, will be available starting later this year, potentially bringing relief to thousands of women who struggle with uncomplicated urinary tract infections. Read More

See how historian Jane Landers and her team are rescuing enslaved Africans’ stories from oblivion and honoring thousands of lives. Read More

Bennett Landman who holds a Stevenson Chair, has more than 2,000 collaborations globally that look at all sorts of different diseases, from the head down to the shins. But the heart of his work remains medicine and the promise of a world where AI-driven imaging leads to earlier diagnoses and better patient outcomes. Read More

Learn about the women who inspire Steven Townsend in his breakthrough research that puts a spotlight on women, their health and discoveries around the healing powers of breast milk. Read More

Learn about the inspiration that drives biomedical engineer Audrey Bowden in her work using light towards breakthroughs in medical issues from cancers to jaundice to ADHD. Read More

Learn about the path that brought dynamic engineering duo Dan Work and Jonathan Sprinkle together and how they're using AI to prevent traffic jams and make highways safer. Read More

See how art collector turned immunologist James Crowe combines abstract thinking with game-changing technology to prevent infectious disease. Read More

Cybele Raver’s ‘Quantum Potential’ podcast explores solutions for humanity’s greatest challenges. Read More